Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials

Previous studies have reported that effect sizes of antidepressants were larger in two-armed than in three-armed or more-armed (multiarmed) randomized trials, where the probability of being allocated to placebo is lower. However, these studies have not taken into account the publication bias, differences among antidepressants, or covariance in multiarmed studies, or examined sponsorship bias. We searched published and unpublished randomized-controlled trials that compared placebo with 21 antidepressants for the acute treatment of major depression in adults. We calculated the ratio of odds ratios (ROR) of drug response over placebo in two-armed versus multiarmed trials for each antidepressant, and then synthesized RORs across all the included antidepressants using the multivariate meta-analysis. A random-effects model was used throughout. Two hundred and fifty-eight trials (66 two-armed and 192 multiarmed trials; 80 454 patients; 43.0% with unpublished data) were included in the present analyses. The pooled ROR for response of two-armed trials over multiarmed trials was 1.09 (95% confidence interval: 0.96–1.24). The ROR did not materially change between types of antidepressants, publication year, or sponsorship. The differences between two-armed versus multiarmed studies were much smaller than were suggested in previous studies and were not significant.

[1]  T. Furukawa,et al.  Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis , 2016, BMJ Open.

[2]  J. Higgins Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[3]  Nicky J Welton,et al.  Evaluating novel agent effects in multiple‐treatments meta‐regression , 2010, Statistics in medicine.

[4]  A. Kiss,et al.  Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. , 2010, The Journal of clinical psychiatry.

[5]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[6]  Maurizio Fava,et al.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD , 2009, European Neuropsychopharmacology.

[7]  John M. Davis,et al.  Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis , 2009, The Lancet.

[8]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[9]  T. Furukawa,et al.  Imputing response rates from means and standard deviations in meta-analyses , 2005, International clinical psychopharmacology.

[10]  Russell L. Kolts,et al.  Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. , 2004, The American journal of psychiatry.

[11]  M. Hotopf,et al.  "Wish Bias" in Antidepressant Drug Trials? , 2004, Journal of clinical psychopharmacology.

[12]  S. Wessely,et al.  Active placebos versus antidepressants for depression. , 2004, The Cochrane database of systematic reviews.

[13]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[14]  R. Dardennes,et al.  Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable. , 2000, The British journal of psychiatry : the journal of mental science.

[15]  R. Bornstein,et al.  A meta-analysis of antidepressant outcome under "blinder" conditions. , 1992, Journal of consulting and clinical psychology.

[16]  A Ehlers,et al.  How "blind" are double-blind studies? , 1991, Journal of consulting and clinical psychology.

[17]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[18]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.